Program Overview Pathophysiology of Hyperglycemia Updated ADAEASD Standard of Care 2017 Delays in Intensification of Therapy The Role of Basal Insulin and GLP1 RA in Controlling Hyperglycemia ID: 714831
Download Presentation The PPT/PDF document "Insulin/GLP-1 Agonist Combinations" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Insulin/GLP-1 Agonist CombinationsSlide2Slide3
Program OverviewSlide4
Pathophysiology of HyperglycemiaSlide5
Updated ADA/EASD Standard of Care, 2017Slide6
Delays in Intensification of TherapySlide7
The Role of Basal Insulin and GLP-1 RA in Controlling HyperglycemiaSlide8
Intensifying Therapy With Basal Insulin and GLP-1 RASlide9
DUAL V: Key ResultsSlide10
DUAL VII: Key ResultsSlide11
LixiLan-O Trial: Study DesignSlide12
LixiLan-L Trial: Study DesignSlide13
LixiLan-O: Patients Achieving Composite EndpointsSlide14
LixiLan-L Trial: Change in HbA1c and Composite EndpointsSlide15
Simultaneous or Sequential Combination:
LixiLan-O and GetGoal DUO-1 TrialsSlide16
Simultaneous or Sequential Combination:
LixiLan-O and GetGoal DUO-1 Trials (cont)Slide17
Simultaneous or Sequential Combination:LixiLan-L and GetGoal Duo-2 TrialsSlide18
Shorter Time to Glycemic Control With IGlarLixi vs Gla-100: HbA1cSlide19
Shorter Time to Glycemic Control With IGlarLixi vs Gla-100: FPGSlide20
Shorter Time to Glycemic Control With IDegLira vs IDeg or LiraglutideSlide21
Patients Who Can Benefit Most From FRCsSlide22
LixiLan-L Subgroup AnalysesSlide23
FRC of Insulin GLP-1 RAs: Key ConsiderationsSlide24
SummarySlide25
Insulin/GLP-1 Agonist Combinations in Primary CareSlide26
Treating T2DM in Primary CareSlide27
FRCs of Basal Insulin/GLP-1 RA: Recap Slide28
The Role of FRCs in Primary CareSlide29
Which Patients Would Benefit Most in Primary Care?Slide30
OutlookSlide31
AbbreviationsSlide32
Abbreviations (cont)